NL-OMON47974已完成不适用
HIV-1 Envelope Sequence Diversity Within the Latent Reservoir in HIV-1 Infected Individuals Initiated on Antiretroviral Therapy (ART) During Acute and Chronic Infection. - GS-US-420-3903
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Ages >= 18 years of age
- •Ability and willingness to provide informed consent
- •Clinically stable on ART without changes in ARV status in the 24 weeks prior to screening. A change in ART >= 60 days prior to study visit for reasons other than virologic failure (eg, tolerability, simplification, drug-drug interaction profile) is allowed
- •Plasma HIV-1 RNA plasma levels < 50 copies/mL at screening
- •At least two documented HIV-1 RNA plasma levels < 50 copies/mL within the last 24 weeks (may include screening HIV-1 RNA plasma level). Results must come from a licensed assay with a lower limit of quantification of <50 copies/mL
- •o Unconfirmed virologic elevations of >= 50 copies/mL (transient detectable viremia, or *blip*) >= 12 weeks prior to screening are acceptable. If the lower limit of detection of the local HIV-1 RNA assay is <50 copies/mL, the plasma HIV-1 RNA level cannot exceed 50 copies/mL on two consecutive HIV-1 RNA tests
- •Have an absolute neutrophil count >= 1500 cell/mm3, platelets >= 150,000/mm3; hemoglobin (Hgb) >= 11.5g/dL (females) or >= 13g/dL (Males)
- •Have a creatinine clearance (CLcr) >=70 mL/min ( >=90 mL/min for leukapharesis subjects only) (using the Cockcroft-Gault method {Cockcroft 1976} based on serum creatinine and actual body weight as measured at screening
- •Ionized calcium level of >=1.1 mmol/L (4.4 mg/dL), serum Mg >= 1.6 mg/dL (for subjects undergoing leukapharesis only)
- •Have liver function tests such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, and total bilirubin normal or below the upper limit of normal at screening
- •Prothrombin Time (PT) < 1 × Upper Limit of Normal (ULN), International Normalized Ratio of prothrombin time (INR) <1.1 × ULN and Activated Partial Thromboplastin Time (APTT) < 1 × ULN
- •Available documented baseline demographic and clinical data
排除标准
- •Positive urine pregnancy test
- •Subjects weighing less than 110 lbs
- •Subjects who have donated more than 400 ml of blood within 56 days of Day 1
- •For subjects undergoing leukapheresis, known allergic reactions to any component(s) of leukapheresis (e.g., citrate, heparin etc)
- •History of opportunistic illness indicative of stage 3 HIV
- •Have any serious or active medical or psychiatric illness (including depression) that, in the opinion of the investigator, would interfere with subject assessment, or compliance with the protocol. This would include renal, cardiac, hematological, hepatic, pulmonary (including chronic asthma), endocrine (including diabetes), central nervous, gastrointestinal (including an ulcer), vascular, metabolic (thyroid disorders, adrenal disease), immunodeficiency disorders other than HIV-1 infection, active infection, or malignancy that are clinically significant or requiring treatment.
- •Have been treated with systemic steroids, immunosuppressant therapies, immunomodulatory therapies, chemotherapeutic agents within 3 months prior to enrollment.
- •Acute or chronic bleeding disorder or use of blood thinners within 2 weeks of Day 1
研究者
相似试验
尚未招募
不适用
HIV-1 evolution after transmission - A cohort study to identify evolution of recently transmitted HIV-1human immunodeficiency virus type110047438NL-OMON32993Academisch Medisch Centrum30
撤回
不适用
HLA-B35 Alleles and AIDSHIV-1AIDSNCT00340223National Cancer Institute (NCI)
尚未招募
不适用
This cross sectional observational study looks at how HIV persists within the brain despite effective antiretroviral treatmentCTRI/2019/05/019320Dr Ameet Dravid
招募中
不适用
HIV-1 evolution after transmission. A cohort study to identify evolution of recently transmitted HIV-1 infection.primary HIV-1 infectionHIV-1 evolutionviral fitnessHuman Leukocyte antigen (HLA)NL-OMON26446Academic Medical Center (AMC)Investigator driven study, no industrial study30
尚未招募
不适用
Course of HIV-infection with different routes of transmissioHIV AIDS1002146010047438NL-OMON30906niversitair Medisch Centrum Groningen45